Management of Focal Motor Seizures in Sturge-Weber Syndrome with Unilateral Leptomeningeal Angioma
First-line treatment for focal motor seizures in Sturge-Weber syndrome should be levetiracetam, which has demonstrated superior efficacy for focal seizures with minimal drug interactions and can be rapidly loaded at therapeutic doses.
Antiepileptic Drug Selection
Sturge-Weber syndrome (SWS) with leptomeningeal angioma presents unique challenges in seizure management. The approach should prioritize:
First-line medication options:
Alternative medication options if levetiracetam fails:
Dosing and Administration
- Begin levetiracetam at 20 mg/kg/day in two divided doses
- Titrate in 20 mg/kg/day increments at 2-week intervals to target dose of 60 mg/kg/day 1
- Monitor for psychiatric side effects which can occur with levetiracetam 2
Monitoring and Follow-up
- Regular neurological examinations every 2-3 months 5
- Brain MRI should be performed every 2-3 months or at any instance of suspected neurological progression 5
- EEG monitoring to assess seizure control and guide medication adjustments 5
- Assess for adverse effects, particularly psychiatric symptoms with levetiracetam 2
Special Considerations for Sturge-Weber Syndrome
Seizures in SWS require particular attention because:
- They are usually the presenting neurological symptom in SWS 6
- Status epilepticus may occur and requires emergency management 6
- Repetitive seizures can increase brain atrophy in the region of the leptomeningeal angioma 6
- Early seizure control is critical to prevent cognitive and motor deterioration 7
Surgical Evaluation
If seizures persist despite appropriate antiepileptic medication:
- Consider surgical evaluation, as surgery has shown favorable outcomes in medically refractory cases 8
- Surgical options may include:
Caregiver Education
- Train caregivers on seizure recognition and management 2
- Provide education on rescue medication administration for prolonged seizures 2
- Emergency services should be called for seizures lasting more than 5 minutes, repeated seizures without regaining consciousness, or breathing difficulties after seizure 2
Common Pitfalls to Avoid
- Delayed treatment: Do not wait for multiple seizures before initiating therapy; early intervention is critical in SWS 6, 7
- Inadequate dosing: Ensure therapeutic doses are reached and maintained
- Failure to consider surgery: In medically refractory cases, surgical intervention should be considered promptly, as it can provide excellent seizure control (up to 80% seizure freedom) 8
- Overlooking comorbidities: Address associated conditions such as glaucoma and cognitive issues
Early and aggressive seizure management in SWS is essential to prevent progressive neurological deterioration and improve long-term outcomes for morbidity, mortality, and quality of life.